Article Details

Autolus Therapeutics plc SEC 10-K Report - TradingView

Retrieved on: 2025-03-20 21:26:45

Tags for this article:

Click the tags to see associated articles and topics

Autolus Therapeutics plc SEC 10-K Report - TradingView. View article details on hiswai:

Excerpt

Total Revenue: $10.1 million, primarily driven by license revenue recognized pursuant to the License and Option Agreement with BioNTech. Cost of Sales ...

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo